DANAHER CORP /DE/ (DHR) Options Risk Score

Run a full DHR options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on DANAHER CORP /DE/ (DHR) right now?

DANAHER CORP /DE/ (DHR) currently scores 36 out of 100 for options catalyst risk (LOW) over a 4-week expiry window. What pushes it there: an upcoming earnings report, 2 recent news items and 7 active legal filings, all landing inside the 4-week window. Below 45 is LOW: DHR's calendar looks clear across this window. Unscheduled news can still move any stock, so a low score is the absence of a known event, not the absence of risk.

DHR shows an IV Rank of 50, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 39%. Read IV Rank alongside the catalyst score: it says how expensive DHR options are, while the score says whether that price is justified by a scheduled event.

The 2026-10-20 earnings report sits inside a standard monthly expiry for DHR, so implied volatility should stay bid into the date and drop sharply once it passes.

DANAHER CORP /DE/ (DHR) current implied volatility and IV Rank

The most recent read on DANAHER CORP /DE/ (DHR) puts its IV Rank at 50 with implied volatility around 39%, alongside a TickerRisk options-risk score of 36/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about DHR's options, see IV Rank explained.

DANAHER CORP /DE/ (DHR) next earnings date — 2026-10-20

DANAHER CORP /DE/ (DHR) reports earnings on 2026-10-20 — about 44 days away, which falls inside a typical options expiry window. DHR's IV Rank is currently 50. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer